Development of strategies for prevention of breast cancer development requires an understanding of the eects of mammary oncogenes on mammary cells at early stages in neoplastic transformation. As mammary oncogenes wnt-1 and int-2 aect dierent signal transduction pathways, we investigated their eects on established mouse mammary epithelial cell lines (MMECLs) re¯ecting early stages in tumorigenesis. Normal interactions between b-catenin and E-cadherin were abrogated in all three immortalized MMECLs and the cells lacked b-catenin-mediated transactivation activity, detectable using a reporter assay, suggesting that alterations in cell adhesion may be very early events in mammary tumorigenesis. Immortalized FSK4 and EL12 cells and hyperplastic TM3 cells were stably transfected with expression vectors encoding wnt-1 or int-2 or the control vector, and drug-selected pooled cells from each line were con®rmed by reverse transcription-polymerase chain reaction to express the transfected oncogene; this expression persisted in the cells analysed in vitro and in vivo. Resultant phenotypic changes depended both on the oncogene and the target mammary cell line. In FSK4 cells, expression of wnt-1 or int-2 resulted in proliferative changes in vitro, including reduced contact inhibition, increased b-catenin expression, and decreased p53 transcriptional activity, but neither oncogene conferred upon those cells the ability to produce tumors in vivo. EL12 cells were highly refractory to the eects of both oncogenes, with the only measurable changes being increased E-cadherin levels induced by both oncogenes and increased proliferation of the int-2-transfected cells in the absence of serum. Parental TM3 cells were phenotypically similar to wnt-1-or int-2-transfected FSK4 cells and displayed an increased rate of proliferation in vitro and markedly increased tumorigenicity in vivo following transfection with int-2 but not with wnt-1. These results suggest that wnt-1 signaling is redundant in the hyperplastic TM3 cells and indicate that wnt-1-induced eects in the immortalized FSK4 and EL12 cells were not sucient to mediate a tumorigenic phenotype. This study showed that the wnt-1 and int-2 oncogenes have similar but distinguishable eects on immortalized MMECLs and that the genetic background of the mammary cells greatly in¯uences the consequences of oncogene expression at early stages of cell transformation. Oncogene (2001) 20, 7645 ± 7657.
Introduction
Both wnt-1 (originally known as int-1) and int-2 were initially discovered by analysis of host cell sequences adjacent to viral integration sites in tumors of mice infected with mouse mammary tumor virus (MMTV) (Nusse et al., 1984; Peters et al., 1984) . When wnt-1 or int-2 was targeted to the mammary gland of transgenic mice, wnt-1 was highly tumorigenic in females whereas int-2 was weakly tumorigenic; the two oncogenes acted synergistically in doubly transgenic animals (Kwan et al., 1992) . It has been shown recently that wnt-1 can also cooperate with TGFa in transgenic animals (Schroeder et al., 2000) .
The two oncogenes aect separate but intersecting signal transduction pathways. Wnt-1 exerts its eects via the multifunctional b-catenin protein (Miller and Moon, 1996; Smalley and Dale, 1999; Polakis, 2000) . Binding of wnt-1 to its receptor,`frizzled', initiates a signaling cascade via the phosphoprotein`dishevelled' that results in phosphorylation and downregulation of glycogen synthase kinase-3 (GSK-3). One of the functions of GSK-3 is to target b-catenin for degradation; therefore, downregulation of GSK-3 by wnt-1 may result in increased b-catenin protein levels. b-catenin has been detected in three forms: bound to E-cadherin as part of a protein complex involved in cell adhesion, associated with TCF/LEF proteins in the nucleus where it is involved in upregulating expression of genes such as myc and cyclin D, or in soluble cytoplasmic form (Clevers and van de Wetering, 1997; Papko, 1997; He et al., 1998; Tetsu and McCormick, 1999) . Current evidence suggests that the oncogenic functions of wnt-1 may be mediated via upregulation of proliferative genes by b-catenin ± TCF/LEF complexes (Aoki et al., 1999; Smalley and Dale, 1999; Polakis, 2000) .
Alterations in the wnt signaling pathway are common in human neoplasia (Pierceall et al., 1995; Smalley and Dale, 1999; Polakis, 2000) . Disruption of cadherin-catenin interactions would increase the free pool of b-catenin, thus increasing the amount of this protein available for potentially tumorigenic interactions with TCF/LEF. This mechanism has been implicated in a variety of human cancers, including colon cancer and melanoma (Rubinfeld et al., 1997; Tetsu and McCormick, 1999; Polakis, 2000) . Although wnt-1 is not expressed in normal mammary tissue, it has been shown that several other wnt family proteins are expressed in the murine mammary gland in a developmentally regulated sequence (Gavin and McMahon, 1992; Weber-Hall et al., 1994; Naylor et al., 2000) .
Int-2/fgf-3 is a member of the ®broblast growth factor (FGF) family. At least 20 dierent FGFs and four FGF receptors (FGFRs) with multiple splice variants have been identi®ed (Klint and ClaessonWelsh, 1999) . Most FGFs are able to bind to several receptors (Galzie et al., 1997) . This implies redundancy in function, but FGFs do exert some gene-speci®c eects. FGF-1, FGF-2, FGF-4, and FGF-7 are expressed during the ductal stage of mammary development; FGF-1 is found mainly in luminal epithelial cells and FGF-2 and FGF-7 are expressed predominantly in the mammary stroma (ColemanKrnacik and Rosen, 1994) . Int-2/fgf-3 is developmentally regulated and not found in normal mammary gland or most adult tissues Jakobovits et al., 1986; Wilkinson et al., 1988) . Expression of dominant-negative FGFR2, a potential receptor for int-2/FGF-3, has been shown to inhibit development of the mammary gland in transgenic mice, suggesting that this receptor may be present on normal mammary epithelium (Jackson et al., 1997) . Most cells in vitro express FGFRs, but the distribution of FGFR expression in vivo is unknown. Binding of FGFs to their receptors triggers the formation of receptor homodimers and heterodimers, which then activate a variety of signaling pathways, including MAP kinase, protein kinase B, and protein kinase C (Klint and Claesson-Welsh, 1999) .
Overexpression of FGFs is associated with uncontrolled cell proliferation in both human and murine cells (Kern et al., 1994; el Yazidi and Boilly-Marer, 1995; McLeskey et al., 1996) , and there is evidence that FGFs may contribute to the development of neoplasia. FGF-2 (bFGF) can stimulate proliferation of mouse mammary epithelial cells in vitro (Medina et al., 1993b) . FGF-3 (int-2) exhibits receptor speci®city that overlaps with that of bFGF (Merlo et al., 1990) and it can substitute for bFGF for growth in soft agar of HC11 cells (Venesio et al., 1992) , suggesting that the two may exert some similar eects. Ectopic expression of int-2 in the mammary glands of transgenic mice is associated with mammary hyperplasia and a low frequency of mammary tumors (Muller et al., 1990; Kwan et al., 1992) . Overexpression of FGF-8 and FGFRs 1 and 4 has been observed in human tumors (Marsh et al., 1999) . Ampli®cation of the int-2 oncogene occurs in some human breast cancer and was noted (Fioravanti et al., 1997) to be associated with a high risk of local-regional recurrence in nodenegative cancers. Taken together, these studies suggest that FGFs, including int-2/FGF-3, may be involved in the development of breast cancer.
Several mouse mammary epithelial cell lines (MMECLs) which represent dierent steps in tumorigenesis have been derived from primary normal or hyperplastic mammary tissue (Kittrell et al., 1992) . These cell lines can be maintained in conventional tissue cultures in the absence of an arti®cial matrix. When early passages of cell lines derived from normal mammary tissue, designated as FSK cells, were transplanted in vivo into cleared mammary fat pads of syngeneic (BALB/c) mice, they formed normal ductal outgrowths that ®lled the fat pad. Some outgrowths could be serially transplanted in vivo for longer periods of time while maintaining normal outgrowth morphology and were designated`EL' for extended life'. EL outgrowths are immortal but otherwise have a normal phenotype . Some outgrowths were obtained which were hyperplastic and gave rise to tumors during passage; these were designated as TM (Medina et al., 1993a) . Cell lines were established in vitro from both EL and TM outgrowths Medina et al., 1993a) and were found to represent sequential steps in mammary tumorigenesis (Kittrell et al., 1992; Jerry et al., 1993; Medina et al., 1993b; Ozbun et al., 1993) . To understand breast cancer development, it is important to determine the eects of mammary oncogenes on nearly normal mammary epithelial cells. In this study we sought to determine if expression of wnt-1 or int-2 can confer proliferative or tumorigenic phenotypes on MMECLs representing the earliest stages of mammary tumorigenesis.
Results

Expression of oncogenes in stably transfected mammary epithelial cells
Stably transfected wnt-1, int-2, and vector cell lines were derived from FSK4, EL12, and TM3 cells as described in Materials and methods. These three MMECLs were chosen for study because they represent very early steps in mammary tumorigenesis. The derivative cell lines studied here were pooled populations of transfected, selected cells, rather than clonal isolates, to avoid possible eects of clonal variation on cell properties. RNA was isolated from transfected cells, and wnt-1 and int-2 sequences were ampli®ed with primers spanning the vector/insert junction. The approach was designed so that the introduced oncogene was speci®cally detected and distinguishable from the endogenous cellular oncogene (Figure 1 ). To ensure that synthesis of reverse transcription-polymerase chain reaction (RT ± PCR) products was speci®c and not due to ampli®cation of residual DNA remaining after puri®cation of the cellular RNA samples, ampli®cation by PCR without prior reverse transcription was attempted. Wnt-1 or int-2 mRNA would be ampli®ed by RT ± PCR but not by Figure 1 Analysis of wnt-1 and int-2 expression in stably transfected MMECLs. Wnt-1 and int-2 sequences were ampli®ed by RT ± PCR from total cellular RNA and detected by staining with ethidium bromide. PCR without prior reverse transcription was performed in parallel to rule out false positives due to ampli®cation of residual DNA. The primers were designed to span the vectorinsert junction (schematic at top) so that only the exogenous genes would be ampli®ed. Cell lines are listed on the left; PCR products are identi®ed on the right side of each panel Oncogene Effects of wnt-1 and int-2 on mammary cells CA Hollmann et al PCR, whereas DNA would be ampli®ed by either procedure. Expression of the transfected wnt-1 or int-2 gene was con®rmed in all oncogene-transfected cell lines; expression was not detected in the negative control cells which were transfected with only the pcDNA3 vector or in the PCR control without prior reverse transcription (Figure 1 ). RT ± PCR using primers speci®c for a 5' internal region of the wnt-1 or int-2 sequence failed to detect expression of the endogenous oncogene in parental MMECLs. This is in agreement with reports by others Jakobovits et al., 1986; Wilkinson et al., 1988 ) that wnt-1 and int-2 expression is normally limited to certain stages of embryonic development and is not detectable in normal mammary gland or most adult tissues. To establish that the introduced oncogenes were stably expressed in vitro, wnt-1 and int-2 expression was veri®ed at high passage levels of the transfected cells. There was no observed loss of either wnt-1 or int-2 expression in any of the pooled cell lines up to the highest passages tested (about 20) after selection. All in vitro and in vivo experiments were performed with cells below passage 15, ensuring that the transfected genes were expressed.
As the functional eects of transfected genes may depend, in part, on their level of expression, relative quantities of wnt-1 and int-2 RNA were measured by comparative RT ± PCR. Actin and wnt-1 or int-2 sequences were ampli®ed from several dilutions of cellular RNA from the stably transfected cells, ranging from 1 mg to 0.016 mg total RNA per reaction. The products were separated on 2% agarose gels, stained with SYBR Gold, and quantitated with a Storm chemiluminescent imager. Intensities of actin and wnt-1 or int-2 RT ± PCR products at several sample dilutions were compared to obtain an estimate of relative expression levels of the transfected genes (compared to the actin control) ( Table 1 ). The levels of exogenous wnt-1 or int-2 expression were similar among FSK4, EL12, and TM3 stably transfected cell lines, with variations less than ®vefold. FSK4 transfectants expressed the highest levels of wnt-1 and the lowest levels of int-2, whereas EL12 transfectants contained the lowest levels of wnt-1 and the highest levels of int-2.
Int-2 but not wnt-1 increases serum-independent proliferation of stably transfected mammary epithelial cells
To determine if wnt-1 or int-2 functions as a growth factor in MMECLs, the serum-independent growth of cells stably transfected with wnt-1, int-2, or the vector control was compared (Figure 2) . Stably transfected FSK4, EL12, and TM3 cells were grown in DMEM:F12 containing 5 ng/ml epidermal growth factor (EGF) and 10 mg/ml insulin and the presence or absence of 1% adult bovine serum. MTT assays were used to compare cell growth in complete medium to growth achieved in the absence of serum. Vector-transfected control TM3 cells proliferated well in the absence of serum, whereas FSK4 and EL12 cells showed a greater than 50% reduction in growth in the absence of serum. This dierence among the MMECLs was statistically signi®cant (P50.01). Int-2 overcame the serum requirement of FSK4 and EL12 cells, but had no statistically signi®cant eect on the serum-independent growth of TM3 cells. Wnt-1 eects on the serum independence of all three stably transfected cell lines were not signi®cant (P40.05), as calculated with the Student-Newman Keuls test.
Wnt-1 and int-2 decrease contact inhibition in FSK4 cells
As both wnt-1 and int-2 have been reported to reduce contact inhibition of cell growth for some cells, the saturation densities of wnt-1 and int-2 stably transfected MMECLs were compared to those of the vectortransfected controls (Figure 3 ). Cells were seeded at a density of 1610 5 per 60-mm dish, triplicate samples were harvested every 2 ± 3 days, cells were stained with Trypan blue, and cell counts were performed to determine the total number of viable cells per dish.
Results of three separate experiments were averaged ( Figure 3 ). Both oncogenes were capable of reducing contact inhibition in FSK4 cells, as re¯ected in signi®cantly higher saturation densities of FSK4wnt and FSK4int cells as compared to the FSK4vector cells (P50.01). EL12 cells grew to a density similar to that of the FSK4 control cells and that saturation density was not aected by either oncogene. The saturation density of TM3vector cells was signi®cantly higher than that of FSK4 or EL12 cells and was not altered by exogenous wnt-1 or int-2 expression.
Int-2 increases the proliferation rate of TM3 cells
To detect possible eects of oncogenes on cell proliferation, the rate of MMECL cell growth was measured with MTT assays. Vector and oncogene stably transfected cells were seeded at a density of 1610 4 cells per well in 24-well plates; quadruplicate samples were quantitated with MTT at 72-h intervals. TM3int cells showed a marked increase in proliferation rate as compared to the other eight cell lines (P50.01) (Figure 4 ). Wnt-1 did not aect the proliferation rate of FSK4, EL12, or TM3 cells, and int-2 did not aect the growth rates of FSK4 or EL12 cells.
Wnt-1 and int-2 increase b-catenin protein levels in FSK4 cells and E-cadherin protein levels in EL12 cells Both wnt-1 and int-2 may exert some eects via GSK3 and b-catenin. To determine if wnt-1 or int-2 aected b-catenin expression, a quantitative enhanced chemiluminescence (ECL)-Western blot assay was designed to compare b-catenin protein levels among the stably transfected MMECLs. Denatured cell lysates were prepared as described in Materials and methods, the total protein concentration of each lysate was determined, and b-catenin was detected by ECLWestern blot. Several dilutions of each lysate were analysed in parallel with A431 cell lysate (positive control and quantitation standard) and ZR-75-30 cell lysate (negative control) (Figure 5a ). Films from two independent experiments were analysed by densitometry. The amount of b-catenin per mg of total cell lysate in the stably transfected MMECLs was compared to the concentration found in A431 cells. TM3 cells expressed the highest levels of b-catenin, and FSK4 cells the lowest. Both wnt-1 and int-2 expression were associated with a twofold increase in b-catenin protein levels in FSK4-derived cells, but the oncogenes did not aect b-catenin levels in the TM3 or EL12 cells ( Figure  5b ).
E-cadherin protein levels in these cells were quantitated by the same method ( Figure 5c ). In vector-transfected cells, E-cadherin levels were proportional to the b-catenin levels, with FSK4 cells containing the lowest levels of both proteins and TM3 cells the highest levels. Wnt-1 expression was associated with an increase in E-cadherin expression in FSK4 cells. Both oncogenes markedly increased Ecadherin levels in EL12 cells, in contrast to their lack of eect on b-catenin protein levels in those cells. Ecadherin levels in TM3-derived cells were not aected by either wnt-1 or int-2 (Figure 5d ). The oncogene eects on b-catenin levels in FSK4 cells were statistically signi®cant, as was the eect of wnt-1 on E-cadherin in the same cells. However, the elevated protein levels in the FSK4 cells did not approach the endogenous levels of b-catenin and E-cadherin present in the EL12 and TM3 cells. The function of b-catenin is determined in part by its intracellular localization. Membrane-associated b-catenin is involved in cell adhesion, whereas nuclear bcatenin may act as a transcription factor. Although membrane-associated b-catenin was detected by immuno¯uorescence staining of human and murine mammary epithelial cell lines used as positive controls, no b-catenin could be detected in parental or transfected FSK4, EL12, or TM3 cell lines (data not shown). As all MMECLs contained b-catenin at levels detectable by Western blot (Figure 5 ), we carried out cell fractionation experiments followed by Western blot analysis to address subcellular localization. b-catenin levels were detectable in both the detergent-soluble (cytoplasmic/nuclear) and detergent-insoluble (membrane associated) cell fractions of the transfected MMECLs ( Figure 6 ). As had been observed using unfractionated cell lysates, both wnt-1 and int-2 expression resulted in increased b-catenin levels in FSK4 cells, whereas neither oncogene aected overall levels in TM3 or EL12 cells.
Membrane association of b-catenin results from its interaction with E-cadherin. To investigate whether bcatenin was associated with E-cadherin in the TM3-, FSK4-, or EL12-derived cell lines, co-immunoprecipitation studies were carried out. b-catenin was precipitated from nondenatured cell lysates with a monoclonal antibody, and proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS ± PAGE). After transfer to a nitrocellulose ®lter, the ®lter was cut so that the 120-kDa E-cadherin and the 92-kDa b-catenin regions were on separate segments and b-catenin and E-cadherin were detected by ECL-Western blot. Large amounts of b-catenin were precipitated from lysates of all cell lines, including all the stably transfected MMECLs and control cells, with the exception of the ZR-75-30 negative control cells. However, signi®cant amounts of E-cadherin were co-precipitated with b-catenin only from the HC11 and A431 positive control cells; co-precipitation of Ecadherin was minimal from the TM3 and EL12 cells (less than 5% of that of HC11 cells) and undetectable from FSK4 cell lysates (Figure 7) . Although Ecadherin levels were low in the FSK4 cells, stably transfected EL12 cells contained almost as much Ecadherin as the A431 cells ( Figure 5 ). Thus, the failure to detect b-catenin-E-cadherin complexes was not simply a re¯ection of very low cadherin levels in the cells.
b-catenin in stably transfected mammary epithelial cells is not transcriptionally active
As b-catenin was detected in the nucleus of TM3vector and TM3wnt cells by immuno¯uorescence, it was plausible that transcriptionally active b-catenin/TCF complexes might be present in those cells. To test this hypothesis, the stably transfected MMECLs were transiently transfected with either a b-catenin-responsive luciferase reporter plasmid containing a TCF/LEF binding site (pTOPFLASH) or a negative control plasmid with a mutated TCF/LEF site (pFOP-FLASH). HCT116 human colon carcinoma cells, which have been shown to activate the pTOPFLASH reporter plasmid, were used as a positive control, and NIH3T3 cells, reported to be unable to activate this plasmid, were chosen as the negative control. To control for variations in transfection eciency, a cytomegalovirus (CMV)-based b-galactosidase plasmid was co-transfected along with pTOPFLASH or pFOPFLASH. Luciferase activity, representing bcatenin-mediated transcription, was measured with the Promega luciferase assay, and b-galactosidase activity, re¯ecting the transfection eciency, was quantitated with the chemiluminescent Galacton assay. pTOPFLASH (b-catenin responsive) and pFOP-FLASH (negative control) luciferase activities were normalized to the b-galactosidase activity in each sample, and the values compared to each other. Whereas b-catenin-mediated transactivation of the pTOPFLASH promoter was observed in the positive control HCT116 cells (2 ± 3-fold activation), no activity was detected in the negative control NIH3T3 cells or in any of the stably transfected MMECLs (Figure 8a ). Luciferase activities in MMECLs transfected with the pTOPFLASH reporter were comparable to those obtained with a promoterless control plasmid, suggesting that there was minimal, if any, transcriptional activity in the cells that was detectable using this assay system.
Both wnt-1 and int-2 expression is associated with reduced p53 transcriptional activity in FSK4 cells Loss of functional p53 is an important step in mammary tumorigenesis. It has recently been reported that b-catenin may increase the level of p53 transcriptional activity (Damalas et al., 1999) . Considering that the stably transfected MMECLs contain detectable amounts of b-catenin (Figure 5 ), the eect of the mammary oncogenes on the transcriptional activity of p53 in the cells was examined using the p2mdm-luc reporter plasmid (Figure 8b ). Negligible p53 transcriptional activity was detected in the TM3-derived cell lines, not unexpected as the TM3 cells contain mutant p53 Ozbun et al., 1993) . In contrast, all three stably transfected EL12 cell lines exhibited moderate, and similar, levels of p53 activity (i.e., the expression of wnt-1 or int-2 had no detectable modulating eect). FSK4vector cells exhibited the highest level of p53 activity among the three MMECLs. This high basal level of p53-mediated transcription was reduced in the presence of each of the transfected oncogenes; wnt-1 expression was associated with a moderate but statistically signi®cant reduction in p53-mediated transcription, whereas int-2 expression resulted in a greater downregulation of p53 activity. Figure 6 Detection of b-catenin in cytoplasmic and membrane-associated cell fractions. Triton X-100 soluble (cytoplasmic/ nuclear) and insoluble (membrane-associated) cell fractions (labeled`S' and`I') were prepared as described in Materials and methods. Proteins (15 mg protein per lane, as measured with the BioRad Dc protein assay) were separated by SDS ± PAGE and bcatenin was detected by Western blot. A431 (`A') and ZR-75-30 (`Z') cells were included as positive and negative controls, respectively Figure 7 Interaction of E-cadherin and b-catenin. b-catenin was immunoprecipitated from whole-cell lysates under nondenaturing conditions, with lysate containing 1 mg total protein immunoprecipitated and loaded for each lane. The precipitated proteins were separated by SDS ± PAGE and transferred to a nitrocellulose membrane. The membrane was cut so that E-cadherin (116 kDa) (a) and b-catenin (92 kDa) (b) were on separate segments, and both proteins were detected by ECL-Western blot with mouse monoclonal antibodies
Oncogene
Int-2 confers a tumorigenic phenotype on hyperplastic TM3 cells
Stably transfected MMECLs were tested in vivo to determine if wnt-1 or int-2 increased their oncogenic potential. TM3-, EL12-, and FSK4-derived cell lines were transplanted into cleared mammary fat pads of syngeneic BALB/c mice. Six fat pads per cell line were inoculated with 1610 6 cells at each site, and tumor formation was monitored for 16 weeks. Vectortransfected cells at the same passage levels were included as controls. TM3int cells were highly and rapidly tumorigenic, with 100% of sites (6/6) forming tumors within 3 weeks (Figure 9 ). Only two tumors were produced by TM3wnt cells, and those appeared slowly (8 and 13 weeks postinjection); one lateappearing tumor was produced by the TM3vector cells (detected at 16 weeks after injection when the experiment was terminated). Only very weak tumorigenic potential was observed with stably transfected FSK4 cells. No tumors were detected following transplantation of any of the stably transfected EL12 cells (data not shown). Standardized mortality ratio analysis (Uitenbroek, 1997) showed that only TM3int cells formed tumors with a statistically signi®cantly higher incidence than the vector control lines (P50.01). The level of int-2 expression varied up to fourfold among the stably transfected cell lines (Table  1) , but this did not correlate with the observed dierences in tumorigenic eects. The level of int-2 mRNA in the highly tumorigenic TM3int cells was intermediate to those of stably transfected EL12 and FSK4 cells, and the EL12int cells, which expressed the highest levels of int-2 transcripts, produced no tumors following transplantation.
Discussion
This study investigated whether mammary oncogenes wnt-1 and int-2 exerted phenotypic eects on immortalized mammary epithelial cells and whether those eects varied, depending on the characteristics of the target mammary cells. Established MMECLs representing discrete early steps in mammary tumorigenesis were selected for analysis. The results unambiguously showed that the genetic background of the aected mammary cell exerts a strong in¯uence on the phenotypic consequences of wnt-1 and int-2 expression.
In normal epithelial cells, E-cadherin and b-catenin are part of membrane-associated complexes at intercellular junctions (Aberle et al., 1996) . In parental FSK4, EL12, and TM3 cells, both proteins could be detected readily by Western blot but they did not co-immunoprecipitate (Figures 5 ± 7) and neither E-cadherin nor bcatenin could be detected at the plasma membrane by immuno¯uorescence. It is likely, therefore, that the normal interaction between E-cadherin and b-catenin is disrupted in the MMECLs. As alterations in cell adhesion and tissue morphology are distinguishing characteristics of cancerous cells, abrogation of an Ecadherin/b-catenin interaction in the MMECLs suggests that these immortalized cells have already incurred some preneoplastic changes (Jansen et al., 1996; Jiang, 1996) and that alterations in cell adhesion may be evident at very early steps of tumorigenesis.
Eects of wnt-1 on MMECLs diered, depending on the target cell line. Wnt-1 presumably functions through eects on b-catenin to increase proliferation of cells in vitro and enhance tumorigenic potential in vivo (Tsukamoto et al., 1988; Hinck et al., 1994; He et al., 1998; Damalas et al., 1999; Shtutman et al., 1999; Tetsu and McCormick, 1999) . Upregulation of b-catenin by wnt-1 was detected only in FSK4 cells, which initially had the lowest level of the endogenous protein among the MMECLs (Figure 5 ). The higher baseline levels of b-catenin in TM3 and EL12 cells and the lack of increase following wnt-1 overexpression in those cells may be due to the constitutive expression of another growth factor that can deregulate GSK3b and thereby cause an increase in b-catenin, making wnt-1 signaling redundant (Sutherland et al., 1993; Saito et al., 1994) . The b-catenin eects which contribute to tumorigenicity are associated with the function of a TCF/LEF-bcatenin complex as a transcription factor (Clevers and van de Wetering, 1997; He et al., 1998; Tetsu and McCormick, 1999) . As none of the MMECLs activated a b-catenin-responsive reporter plasmid (Figure 8) , it is possible that the potential tumorigenic eects of wnt-1 were inhibited by some interruption of the b-catenin-TCF signaling pathway. In contrast to a previous observation of an upregulation of p53 transcriptional activity in human lung tumor cells in response to increased b-catenin expression (Damalas et al., 1999) , we found reduced p53 function in stably transfected FSK4wnt cells (Figure 7b ). Parental FSK4, TM3 and TM12 cells (derived from EL12) contain detectable p53, with the sequence being wild-type in FSK4 and TM12 cells and mutant in TM3 cells Ozbun et al., 1993; Medina et al., 1998) . Mutations in p53 are often associated with abrogation of function (Vogelstein and Kinzler, 1992) , and the mutant p53 in TM3 cells has been shown to be transcriptionally inactive (PJ Bonilla and JS Butel, unpublished) . It is possible that the eect observed by Damalas et al. (1999) was mediated by a transactivation-dependent function of b-catenin, whereas transactivation-independent eects of b-catenin or wnt-1 may be involved in our system. Some wnt family proteins reportedly modulate a second signal transduction pathway involving calmodulin kinase II and protein kinase C (Kuhl et al., 2000) . Alternatively, the MMECLs may contain some bcatenin transcriptional activity that was not detected by the reporter assay, or dierences may exist among cells in signal transduction events downstream of bcatenin-mediated transcription.
Ectopic expression of int-2 induces cell proliferation in vitro and hyperplasia in transgenic animals (Dixon et al., 1989; Muller et al., 1990; Kwan et al., 1992) . A related protein, bFGF, has FGF receptor anities similar to that of int-2 and increases the proliferation of MMECLs in the absence of serum (Medina et al., 1993b) . Int-2 can replace bFGF in some in vitro transformation assays (Merlo et al., 1990) . Results reported here showing an increase in serum-independent proliferation by FSK4 and EL12 cells following transfection with int-2 support these observations. Although TM3 cells expressing int-2 showed no reduction in serum dependence, that was not surprising as the parental TM3 cells grew eciently in serumde®cient medium, and conditioned medium from those cells allowed EL12 cells to survive in the absence of serum (data not shown), suggesting that TM3 cells overexpress some other growth factor. It is possible that this putative second factor may synergize with the proliferative eects of int-2 (Figure 4 ) and the absence of functional p53 (Figure 8 ) to provoke the strong tumorigenic phenotype displayed when int-2-transfected TM3 cells were transplanted into syngeneic mice (Figure 9 ). In a recent study, myoepithelial cells from an irradiated mouse that were transfected with int-2 also produced tumors in vivo with a short latency (20 days) (Hajitou et al., 1998) . Identical tumor latencies were observed with cells having three dierent expression levels of int-2. This suggests that the increased tumorigenicity of the TM3int cells in this study was not due to an abnormally high expression of the transfected gene.
Targeted int-2 expression in transgenic mice is associated with mammary hyperplasia and tumor development (Muller et al., 1990; Kwan et al., 1992) . The negligible eects of int-2 expression on the Oncogene Effects of wnt-1 and int-2 on mammary cells CA Hollmann et al tumorigenicity of immortalized EL12 and FSK4 cells observed in this study are not in con¯ict with the transgenic mouse data. As multiple genetic changes are required to convert a normal mammary cell to a malignant state, the total number of aected cells in a transgenic animal as compared to the number of experimental cultured cells is signi®cant. In transgenic mice, int-2 expression would be expected to occur in every mammary cell in every mammary gland, providing a large hyperplastic substrate in which cooperating mutagenic events might occur to give rise to a malignant cell. The transfected immortalized MMECLs in this study represented much smaller cell populations and underwent fewer cell generations relative to the cells in the mammary glands of transgenic mice. In contrast to the EL12 and FSK4 cells, however, the highly tumorigenic response of the TM3 cells to int-2 expression indicates that those cells of hyperplastic origin must have a genetic background that allows int-2 functional eects to produce a neoplastic cell phenotype. We do not know what the cellular event(s) are that allow int-2 to mediate tumorigenic eects in TM3 cells, but we speculate that one possible cooperating cellular change may be the absence of p53 function. Mutation or deletion of p53 has been shown to be associated with decreased genomic stability both in vitro and in vivo and with an increased susceptibility to tumors in vivo (Donehower et al., 1992 (Donehower et al., , 1995 . As TM3 cells lack transcriptionally active p53, it is possible that diminished p53 activity permitted the accumulation of mutations that cooperated with int-2 expression to result in tumorigenic transformation. We are not aware of other reports of an int-2 eect on p53, but it has been reported that bFGF (FGF-2), which binds the same receptors and has similar growth eects on mammary cells in vitro, can downregulate p53 in rat ®broblasts by upregulating cellular levels of Mdm2 (Shaulian et al., 1997) . It is possible also that the int-2 eect on p53 activity may be mediated through c-myc, which has been shown to be induced by growth factors and to reduce the activity of p53 (Obaya et al., 1999) .
These studies show that wnt-1 and int-2 have similar, albeit distinguishable, eects on MMECLs in vitro (Table 2 ). In addition, we have clearly demonstrated that the eects of these oncogenes in vitro and in vivo is dependent, at least in part, on host cell factors (genetic background of the cell). The immortalized FSK4 cells displayed a number of similar phenotypic changes following transfection with either wnt-1 or int-2, including decreased contact inhibition, increased bcatenin levels, and decreased p53 transcriptional activity. The immortalized EL12 cells were much less responsive to the eects of these oncogenes, with the only common change being increased E-cadherin levels. Int-2, in keeping with its growth factor heritage, mediated reduced serum dependence for both the FSK4 and EL12 MMECLs. The dierential responses of the immortalized FSK4 and EL12 cells to the oncogenes suggests that the two MMECLs representing very early steps in tumorigenesis may be derived from dierent cell types. TM3 cells displayed no detectable phenotypic changes in vitro after transfection with wnt-1, but showed increased proliferation following transfection with int-2 and the int-2 transfectants became highly tumorigenic in vivo. Finally, it appears that int-2 is not a stage-speci®c oncogene, as it exerted measurable phenotypic eects on MMECLs representing dierent stages of mammary tumorigenesis.
Materials and methods
Plasmids
Plasmids pBSint1 and pBSint2, which contain wnt-1 and int-2 cDNA, respectively, were obtained from H Varmus, National Institutes of Health, Bethesda, MD, USA. Mammalian expression vectors were constructed by subcloning the cDNAs into pcDNA3, a CMV-based mammalian expression vector containing a neomycin resistance gene, from Invitrogen. pcDNA3-lacZ (Invitrogen) and pcDNA3-luc (constructed by S Chua, Baylor College of Medicine) are based on the same pcDNA3 plasmid but express b-galactosidase and luciferase, respectively. A luciferase-expressing b-catenin/ TCF reporter plasmid (pTOPFLASH) and a matching negative control with a mutated TCF binding site (pFOP-FLASH) were provided by Dr H Clevers (Utrecht, Netherlands) (Korinek et al., 1997) . Plasmid p2mdm-luc is a p53 reporter plasmid containing the mdm-2 promoter upstream of a luciferase gene and was supplied by G Lozano (M.D. Anderson Cancer Center, Houston, TX, USA).
Origin and maintenance of cell lines
Mouse mammary cell lines FSK4, EL12, and TM3 were selected for study as representatives of early stages of mammary tumorigenesis (Kittrell et al., 1992; Jerry et al., 1993; Medina and Kittrell, 1993; Medina et al., 1993a,b; Ozbun et al., 1993) . The FSK4 cells were derived from primary mammary epithelial cells, the EL12 cell line was from an outgrowth line that formed morphologically normal ductal outgrowths in cleared syngeneic mammary fat pads, and the TM3 cells were established from a stable hyperplastic outgrowth (Kittrell et al., 1992) . The TM3 hyperplastic outgrowth has the unusual characteristic of spontaneous regression (Bonnette et al., 1999) . None of the cell lines from tumors when inoculated in vivo. Mouse mammary epithelial cells were maintained in DMEM:F12 medium, pH 7.6 (Life Technologies, Inc., Rockville, MD, USA) containing 15 mM HEPES (Sigma, St. Louis, MO, USA), 2% adult bovine serum (Hyclone Laboratories, Logan, UT, USA or Atlanta Biologicals, Norcross, GA, USA), 10 mg/ml insulin (Sigma), 5 ng/ml EGF (Schering Corp., Bloom®eld, NJ, USA), 63 mg/ ml penicillin G potassium (Irvine Scienti®c, Santa Ana, CA, USA), and 100 mg/ml streptomycin sulfate (Irvine Scienti®c) or in RPMI medium, pH 7.6 (Life Technologies) containing 10 mM HEPES, 0.6% sodium bicarbonate (Life Technologies), 10% fetal calf serum (Life Technologies), 2.5 g/l glucose, 1 mM sodium pyruvate (Life Technologies), 10 mg/ ml insulin, 5 ng/ml EGF, 5 mg/ml gentamycin sulfate, 63 mg/ ml penicillin G potassium, and 100 mg/ml streptomycin sulfate at 378C, in an atmosphere of 5% CO 2 . For passage, cells were rinsed in Solution A (1.8 g/l glucose, 7.6 g/l NaCl, 0.4 g/l KCl, 0.14 g/l Na 2 HPO 4 , 7.15 g/l HEPES, 1.24 mg/l phenol red, pH 7.6), detached using 2.4 mg/ml Dispase in Puck's Saline A (8.0 g/l NaCl, 0.4 g/l KCl, 1.0 g/l glucose, 0.15 g/l MgCl 2 .6H 2 O, 0.6 g/l NaHCO 3 , 5 mg/l phenol red, pH 7.6), pelleted, resuspended in medium, and inoculated into fresh medium at a split ratio of 1 : 3. Several cell lines were obtained from the American Type Culture Collection to use as controls in protein expression and transcriptional transactivation assays. Human breast carcinoma cells T-47D (express E-cadherin and b-catenin) (Pierceall et al., 1995) , human breast tumor cells ZR-75-30 (E-cadherin and bcatenin de®cient) (Pierceall et al., 1995) , human thyroid carcinoma A431 cells (positive control for E-cadherin and bcatenin antibody reactions), mouse embryo ®broblasts NIH3T3 (lack transcriptionally active b-catenin) (Hsu et al., 1998) , and human colon carcinoma HCT116 cells (positive control for b-catenin-mediated transactivation) (Korinek et al., 1997) were maintained as recommended by the American Type Culture Collection.
Derivation of stably transfected cell lines FSK4, EL12, and TM3 cells were transfected with plasmids pcDNA3int1, pcDNA3int2 or the pcDNA3 vector control, as described previously (Hollmann et al., 2000) . Selection in G418 (140 mg/ml active concentration) was started 48 h after transfection, and G418-resistant colonies were pooled to generate stably transfected cell lines. Transient transfections for transactivation assays were performed similarly, except that 5 ml/ml Cytofectene (BioRad) and 1.6 mg/ml DNA were used to transfect EL12 cells. Cells were transfected at passages lower than 20, and stably transfected cells were maintained below passage 15 (following selection), with most experiments performed at passages 4 to 10.
Analysis of gene expression
Cellular DNA for analysis by PCR was puri®ed with the Wizard Genomic DNA kit (Promega). Total cellular RNA was puri®ed from tissue samples and cultured cells with the RNeasy kit (Qiagen) as described by the manufacturer, incubated in 1 U/50 ml DNase (Promega) in DNase buer (50 mM Tris, 1 mM EDTA, 10 mM MgCl 2 , 0.1 mM DTT, pH 7.8), and repuri®ed with the Qiagen quick cleanup protocol. RT ± PCR analysis of RNA was performed with the GeneAMP RNA PCR kit (Perkin-Elmer). One mg total cellular RNA was used per 20-ml reaction, and cDNA synthesis was carried out with the random hexamer primer at 258C for 10 min and 428C for 45 min, followed by a 5-min inactivation step at 998C. PCR ampli®cation was performed for 35 to 40 cycles of 15 s denaturing at 948C, 15 s annealing at 57.58C (int-2) or 608C (wnt-1, neo or actin), and 45 s extension at 728C in a Perkin Elmer 2400 Thermocycler. The primers used for PCR ampli®cation were the following: actin, 5' ATG CCT CTG GTC GTA CCA CGG GCA, 3' CTT GCT GAT CCA CAT CTG GAG GTG; neo, 5' TGA ACA AGA TGG ATT GCA CGC AGG, 3' CTC AGA AGA ACT CGT CAA GAA GGC; wnt-1, 5' ATC CAT CTC TCC CAC CTC CTA C, 3' GCT GAT CAG CGA GCT GTA GCA TTT; int-2, 5' CTG ATG AAG AAA TTT GGC TGT AGG, 3' AGC TAT TTA GGT GAC ACT ATA G. The wnt-1 and int-2 primer sets were designed to span the vector/ insert junction in order to speci®cally detect the introduced oncogene; the 5' primer is speci®c for wnt-1 or int-2 sequences whereas the 3' primer in each set binds SP6 sequences. RT ± PCR ampli®cation products were separated on a 2% TAE agarose gel and stained with ethidium bromide for photography or with SYBR Gold (Molecular Probes) for quantitation with a Storm chemiluminescence imager.
MTT cell growth assays
To measure serum-independent growth, cells were seeded into 24-well tissue culture plates at 5610 4 viable cells/well in complete medium and were allowed to attach overnight. The cells were refed with serum-de®cient or complete medium at 16 h, 3 days, and 5 days. After 6 days, the cells were quantitated with MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) (Sigma), a dye that is metabolized by the mitochondria to yield a relative comparison of the number of metabolically active cells (Mosman, 1983) . Onetenth volume of 5 mg/ml MTT was added to each well, and the cells were incubated for 4 h at 378C in 5% CO 2 . The metabolized MTT was solubilized by addition of three volumes of isopropanol containing 0.04 N HCl and was quantitated by measuring absorbances at 570 nm (MTT) and 630 nm (background) with a spectrophotometer. To measure rates of cell proliferation, cells were seeded into 24-well plates at 1610 4 cells/well in complete medium. Quadruplicate samples were quantitated at 3-day intervals with MTT.
Western blot
Cells were lysed in denaturing lysis buer (10 mM Tris pH 7.4, 1% SDS) at 1008C for 5 min. The lysate was homogenized by shearing through a 26G needle, and debris was removed by centrifugation at room temperature for 5 min. Total protein concentration of the supernatant was determined with the BioRad Dc protein assay reagent and 5 ± 30 mg total protein per lane was separated by SDS ± PAGE on an 8% acrylamide/0.21% bisacrylamide gel. The proteins were transferred to a nitrocellulose membrane by electrophoretic transfer at 1 ampere for 1.5 h, and the membrane was blocked overnight at 48C in TBS (20 mM Tris, 137 mM NaCl, pH 7.6) containing 5% dry milk and 0.2% Tween-20 (Sigma). The membrane was washed six times for 5 min in TBS containing 0.2% Tween-20 (TTBS) and then primary antibody C19220 (b-catenin, Transduction Laboratories) or C20820 (E-cadherin, Transduction Laboratories) diluted 1 : 4000 in TTBS was added. After a 1-h incubation at room temperature, the blot was washed in TTBS, and anti-mouse IgG antibody (Vecta Stain kit, Vector Laboratories, Burlingame, CA, USA) was added at a dilution of 1 : 4000 in TTBS. The blot was incubated for 30 min at room temperature, washed in TTBS, and then avidin-biotin complex-peroxidase (Vecta Stain kit) was added at a dilution of 1 : 2000. After another 30-min incubation at room temperature, the blot was washed in TBS and incubated for 
Cell fractionation
Triton X-100 soluble (cytoplasmic/nuclear proteins) and insoluble (membrane-associated components) cell fractions were prepared as follows. Cells were lysed in nondenaturing lysis buer (150 mM NaCl, 10 mM Tris pH 7.4, 1 mM EDTA, 1 mM EGTA, 50 mM Na 4 P 2 O 7 , 1% Triton X-100, 0.5% NP-40), were detached with a cell scraper, and were transferred to a microcentrifuge tube. The lysate was centrifuged for 15 min at 48C to pellet debris, and the supernatant (Triton-X soluble fraction) was removed. The pellet was solubilized in denaturing lysis buer (1% SDS, 1 mM sodium orthovanadate, 10 mM Tris pH 7.4), was heated to 1008C for 5 min, and was sheared through a 26G needle. Insoluble debris was removed by centrifugation for 5 min at room temperature, and the supernatant (Triton-X insoluble fraction) was removed.
Co-immunoprecipitation
Cells were lysed by a 30-min incubation at 48C in nondenaturing buer (150 mM NaCl, 10 mM Tris pH 7.4, 1 mM EDTA, 1 mM EGTA, 50 mM Na 4 P 2 O 7 , 1% Triton X-100, 0.5% NP40, 0.2 mM sodium vanadate [Sigma], 3 mM H 2 O 2 , 100 mg/ml PefaBloc [Roche Molecular Biochemicals], 2 mg/ml leupeptin [Roche Molecular Biochemicals], 1 mg/ml p-toluenesulfonyl-L-arginine-methyl ester [Sigma] ). Debris was removed by centrifugation at 48C, and protein concentration of the supernatant was determined as described above. The lysates were diluted with nondenaturing lysis buer to a ®nal protein concentration of 1 mg/ml and were precleared with 50 ml/ml of Staph A immunoadsorbant with constant mixing for 30 min at 48C. b-catenin was precipitated with 10 ml/ml anti-b-catenin antibody C19220 and 50 ml/ml protein A agarose (Life Technologies), after which the protein A beads were washed three times in nondenaturing lysis buer. Precipitated proteins were eluted at 1008C with disruption buer (4% w/v SDS, 4% v/v b-mercaptoethanol, 10% glycerol, 50 mM Tris pH 6.8, 0.005% bromophenol blue), were separated by SDS ± PAGE, and were transferred to a nitrocellulose membrane as described above. The membrane was cut so that E-cadherin (120 kDa) and bcatenin (92 kDa) were on separate fragments, and both proteins were detected by ECL-Western blot.
Transcriptional transactivation assays
Cells were transfected with a mixture of pcDNA3-lacZ and p2mdm-luc (p53 reporter), pTOPFLASH (b-catenin reporter), or pFOPFLASH (negative control) at a ratio of 1 : 20 and were incubated for 48 h at 378C. The cells were rinsed twice in cold PBS and cell lysates were prepared with reagents from the Promega Luciferase Assay Kit as described by the manufacturer. To measure b-galactosidase activity, 20 ml of cell extract was mixed with 200 ml b-galactosidase reaction buer (100 mM sodium phosphate pH 8.0, 1 mM magnesium chloride, 1% v/v Galacton Plus [Perkin Elmer]) in a luminometer tube, and the mixture was incubated for 1 h at room temperature. The reaction was stopped by addition of 300 ml of light emission accelerator buer (10% v/v Emerald II accelerator [Perkin Elmer], 0.2 N sodium hydroxide), and light emission was measured in a luminometer immediately after addition of accelerator buer. To measure luciferase activity, 50 ml lysate was mixed with 50 ml luciferase substrate (Promega) and light emission was measured with a luminometer immediately after addition of substrate. Luciferase activity was normalized to b-galactosidase activity to correct for variations in transfection eciency and cell number, and then luciferase activities from p2mdm-luc (p53 responsive) and pFOPFLASH (negative control) were compared.
Tumorigenicity assays
Inbred BALB/c mice were bred and maintained in a closed conventional animal facility at Baylor College of Medicine, Houston, TX, USA. To investigate the in vivo tumorigenicity of MMECLs, mammary fat pads were cleared in 3-week-old female mice (Medina, 1973) . Stably transfected cell lines were injected into the cleared mammary fat pads at 1610 6 cells per site, six sites per cell line. The mice were palpated biweekly and monitored for tumor formation for 16 weeks. Tumors were excised and ®xed for histological sectioning (Kittrell et al., 1992; Medina et al., 1993a) . At the termination of the experiment, whole-mount preparations of mammary glands were examined histologically for small tumors that had not been palpated. Abbreviations CMV, cytomegalovirus; ECL, enhanced chemiluminescence; EGF, epidermal growth factor; FGF, ®broblast growth factor; FGFR, FGF receptor; MMECL, mouse mammary epithelial cell line; MMTV, mouse mammary tumor virus; MTT, 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide; PAGE, polyacrylamide gel electrophoresis; PBS, phosphate-buered saline; RT ± PCR, reverse transcription polymerase chain reaction; SDS, sodium dodecyl sulfate
